PCL microspheres based functional scaffolds by bottom-up approach with predefined microstructural properties and release profiles.

Advanced tissue engineering approaches rely upon the employment of biomaterials that integrate biodegradable scaffolds with growth factor delivery devices to better guide cellular activities and enhance tissue neogenesis. Along these lines, here we proposed a bottom-up approach for the realization of bioactive scaffolds with controllable pore size and interconnection, combined with protein-loaded polymeric microcarriers acting as local chrono-programmed point source generation of bioactive signals. Bioactive scaffolds are obtained through the thermal assembly of protein activated poly(epsilon-caprolactone) (PCL) microspheres prepared by double emulsion and larger protein free PCL microspheres obtained by single emulsion. It is shown that the pore dimension, interconnectivity and mechanical properties in compression of the scaffold could be predefined by an appropriate choice of the size of the protein-free microparticles and process conditions. Protein-loaded microparticles were successfully included within the scaffold and provided a sustained delivery of a model protein (BSA). These matrices offer the possibility to concurrently modulate and control the size and extension of the porosity, mechanical properties and the spatial-temporal distribution of multiple bioactive signals.

[1]  D. Winslow,et al.  Advances in Experimental Techniques for Mercury Intrusion Porosimetry , 1984 .

[2]  J. A. Cooper,et al.  Tissue engineering: orthopedic applications. , 1999, Annual review of biomedical engineering.

[3]  Yoshito Ikada,et al.  Challenges in tissue engineering , 2006, Journal of The Royal Society Interface.

[4]  P. Ma,et al.  Polymeric Scaffolds for Bone Tissue Engineering , 2004, Annals of Biomedical Engineering.

[5]  Buddy D Ratner,et al.  Photo-patterning of porous hydrogels for tissue engineering. , 2007, Biomaterials.

[6]  Antonios G. Mikos,et al.  Review: Biodegradable Polymeric Scaffolds. Improvements in Bone Tissue Engineering through Controlled Drug Delivery , 2005 .

[7]  J. Vacanti,et al.  Tissue engineering: a 21st century solution to surgical reconstruction. , 2001, The Annals of thoracic surgery.

[8]  E. Pamuła,et al.  Hydrolytic degradation of porous scaffolds for tissue engineering from terpolymer of l-lactide, ε-caprolactone and glycolide , 2005 .

[9]  C T Laurencin,et al.  Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair. , 1996, Journal of biomaterials science. Polymer edition.

[10]  B D Boyan,et al.  Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.

[11]  V. Guarino,et al.  Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic , 2008 .

[12]  Dehong Chen,et al.  Polycaprolactone microparticles and their biodegradation , 2000 .

[13]  C. Laurencin,et al.  Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair. , 2003, Biomaterials.

[14]  Byung-Soo Kim,et al.  Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. , 2006, Biomaterials.

[15]  Yi Yan Yang,et al.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. , 2001, Biomaterials.

[16]  Nureddin Ashammakhi,et al.  Topics in Tissue Engineering , 2004 .

[17]  Cato T Laurencin,et al.  The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. , 2002, Journal of biomedical materials research.

[18]  U A Stock,et al.  Tissue engineering: current state and prospects. , 2001, Annual review of medicine.

[19]  David J. Mooney,et al.  Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.

[20]  R Langer,et al.  Prospects for organ and tissue replacement. , 2001, JAMA.

[21]  Paolo A Netti,et al.  A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analogue. , 2007, Biomaterials.

[22]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[23]  D H Kohn,et al.  Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.

[24]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[25]  D E Ingber,et al.  Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. , 1993, Journal of biomedical materials research.

[26]  Laura Indolfi,et al.  Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Cato T Laurencin,et al.  In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. , 2006, Biomaterials.

[28]  Cato T. Laurencin,et al.  STUDIES ON THE DEVELOPMENT OF A TISSUE ENGINEERED MATRIX FOR BONE REGENERATION , 1998 .

[29]  Fergal J. O'Brien,et al.  Tissue Engineering for Orthopaedic Applications , 2006 .

[30]  A. Mikos,et al.  Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. , 2006, Advances in biochemical engineering/biotechnology.

[31]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[32]  Egon Matijević,et al.  Surface and Colloid Science , 1971 .

[33]  J Gillard,et al.  Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. , 1999, International journal of pharmaceutics.